Latest Breaking News On - Rajeev juneja - Page 3 : comparemela.com

Top 10 Indian Healthcare Billionaires Of 2024

Top 10 Indian Healthcare Billionaires Of 2024
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.

United arab emiratesSudhir mehtaRajeev junejaDilip shanghviSamir mehtaRamesh junejaCyrus poonawallaShamsheer vayalilZydus lifesciencesPankaj patelCyrus poonawalla groupSun pharmaceuticalsBain companyBurjeel holdingsTorrent groupIntas pharmaceuticals

Mankind Pharma to sell OTC business on a slump-sale basis to yet to be incorporated subsidiary

Mankind Pharma to sell OTC business on a slump-sale basis to yet to be incorporated subsidiary
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Rajeev junejaMankind consumer products pvt ltdMinistry of corporate affairsMankind pharmaCorporate affairsConsumer healthcareVice chairman

Mankind joins race for Apax s surgical supplies company Healthium Medtech

Mankind Pharma, in partnership with ChrysCapital, is considering a bid for Healthium Medtech, a surgical supplies company owned by Apax Partners. This move follows ChrysCapital s recent sale of its stake in Mankind Pharma. Other potential bidders for Healthium include KKR, Novo Nordisk, Hillhouse, Blackstone, and EQT.

Healthium medtechRajeev junejaNovo nordiskCapital internationalCovidien holdingSingapore government investment corporationMankind pharmaApax partnersGovernment investment corporationSutures indiaQuinag acquisition

Presenting the winners of The ET Awards for Corporate Excellence 2023

The ET Awards recognize the most innovative and best-performing companies and honour people who have raised the bar for excellence. Watch it live on March 15.

Ramesh junejaLeena nairRameshc junejaPharma rajeev junejaLarsen toubroRajeev junejaCompany of the yearAdani green energyIndia incCorporate excellenceCold warChairman emeritusMankind pharmaHina nagarajanDiageo indiaState bank

Mankind Pharma: ETMarkets Management Talk | Mankind Pharma MD explains 2 reasons behind drop in margins

Mankind Pharma s gross margin fell due to inventory accruals and production capacity issues. Revenue growth driven by domestic business and exports. Consumer healthcare business undergoing turnaround with market share gains. Incremental gains expected in chronic therapies. Focus on secondary sales, rural penetration, flagship brands, and market share growth. Strengthening IT systems, strategic focus on user base, and product premiumization.

Uttar pradeshRajeev junejaIndian school of businessOffering collegeMankind pharmaManaging directorVice chairmanLeadership excellenceProduct officerOperations officerMight also likePrega newsAnti diabetic